Therapeutic modalities of deferiprone in Parkinson's disease: SKY and EMBARK studies

David Devos, Olivier Rascol, Wassilios G Meissner, Alexandra Foubert-Samier, Simon Lewis, Christine Tranchant, Mathieu Anheim, David Maltête, Philippe Remy, Karla Eggert, Heidi Pape, Christian Geny, Philippe Couratier, Camille Carroll, Ray Sheridan, David Burn, Nicola Pavese, Jason Raw, Daniela Berg, Oksana Suchowersky, Lorraine V Kalia, Andrew Evans, Sophie Drapier, Teodor Danaila, Alfons Schnitzler, Jean-Christophe Corvol, Gilles Defer, Noemi Toiber Temin, Caroline Fradette, Fernando Tricta, Caroline Moreau, Unknown

Open source

DOI: 10.1177/1877718x241300295
Published: 2024-12-27
Container: Journal of Parkinson’s Disease
Publisher: SAGE Publications
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1177/1877718x241300295,
  title = {Therapeutic modalities of deferiprone in Parkinson's disease: SKY and EMBARK studies},
  author = {David Devos and Olivier Rascol and Wassilios G Meissner and Alexandra Foubert-Samier and Simon Lewis and Christine Tranchant and Mathieu Anheim and David Maltête and Philippe Remy and Karla Eggert and Heidi Pape and Christian Geny and Philippe Couratier and Camille Carroll and Ray Sheridan and David Burn and Nicola Pavese and Jason Raw and Daniela Berg and Oksana Suchowersky and Lorraine V Kalia and Andrew Evans and Sophie Drapier and Teodor Danaila and Alfons Schnitzler and Jean-Christophe Corvol and Gilles Defer and Noemi Toiber Temin and Caroline Fradette and Fernando Tricta and Caroline Moreau and Unknown},
  year = {2024},
  journal = {Journal of Parkinson’s Disease},
  doi = {10.1177/1877718x241300295},
  url = {https://doi.org/10.1177/1877718x241300295}
}

RIS

TY  - JOUR
TI  - Therapeutic modalities of deferiprone in Parkinson's disease: SKY and EMBARK studies
AU  - David Devos
AU  - Olivier Rascol
AU  - Wassilios G Meissner
AU  - Alexandra Foubert-Samier
AU  - Simon Lewis
AU  - Christine Tranchant
AU  - Mathieu Anheim
AU  - David Maltête
AU  - Philippe Remy
AU  - Karla Eggert
AU  - Heidi Pape
AU  - Christian Geny
AU  - Philippe Couratier
AU  - Camille Carroll
AU  - Ray Sheridan
AU  - David Burn
AU  - Nicola Pavese
AU  - Jason Raw
AU  - Daniela Berg
AU  - Oksana Suchowersky
AU  - Lorraine V Kalia
AU  - Andrew Evans
AU  - Sophie Drapier
AU  - Teodor Danaila
AU  - Alfons Schnitzler
AU  - Jean-Christophe Corvol
AU  - Gilles Defer
AU  - Noemi Toiber Temin
AU  - Caroline Fradette
AU  - Fernando Tricta
AU  - Caroline Moreau
AU  - Unknown
PY  - 2024
JO  - Journal of Parkinson’s Disease
DO  - 10.1177/1877718x241300295
UR  - https://doi.org/10.1177/1877718x241300295
ER  -

APA

Devos, D., Rascol, O., Meissner, W. G., Foubert-Samier, A., Lewis, S., Tranchant, C., Anheim, M., Maltête, D., Remy, P., Eggert, K., Pape, H., Geny, C., Couratier, P., Carroll, C., Sheridan, R., Burn, D., Pavese, N., Raw, J., Berg, D., Suchowersky, O., Kalia, L. V., Evans, A., Drapier, S., Danaila, T., Schnitzler, A., Corvol, J., Defer, G., Temin, N. T., Fradette, C., Tricta, F., Moreau, C., & Unknown (2024). Therapeutic modalities of deferiprone in Parkinson's disease: SKY and EMBARK studies. Journal of Parkinson’s Disease. https://doi.org/10.1177/1877718x241300295

Source records

crossref · retrieved 2026-09-27T10:50:46.734Z